IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.339
EU - Europa 11.457
AS - Asia 6.197
SA - Sud America 926
Continente sconosciuto - Info sul continente non disponibili 492
AF - Africa 80
OC - Oceania 25
Totale 43.516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.152
RU - Federazione Russa 3.468
UA - Ucraina 2.806
VN - Vietnam 1.840
CN - Cina 1.827
SG - Singapore 1.802
GB - Regno Unito 1.206
SE - Svezia 1.115
DE - Germania 1.027
BR - Brasile 721
FR - Francia 600
IT - Italia 512
FI - Finlandia 342
KR - Corea 129
PL - Polonia 121
IN - India 104
CA - Canada 91
HK - Hong Kong 86
BD - Bangladesh 78
EU - Europa 62
AR - Argentina 61
IQ - Iraq 59
NL - Olanda 43
VE - Venezuela 36
CO - Colombia 35
JP - Giappone 35
TR - Turchia 35
MX - Messico 29
SA - Arabia Saudita 29
BE - Belgio 28
PK - Pakistan 28
EC - Ecuador 26
AT - Austria 24
LV - Lettonia 24
ES - Italia 23
UZ - Uzbekistan 22
ZA - Sudafrica 21
AU - Australia 19
IE - Irlanda 19
PH - Filippine 19
ID - Indonesia 17
MA - Marocco 15
CR - Costa Rica 13
TN - Tunisia 12
CL - Cile 11
JM - Giamaica 11
PY - Paraguay 11
DK - Danimarca 10
PE - Perù 10
PT - Portogallo 10
BG - Bulgaria 9
CZ - Repubblica Ceca 9
BO - Bolivia 8
JO - Giordania 8
KE - Kenya 8
MY - Malesia 8
AZ - Azerbaigian 7
HU - Ungheria 7
IL - Israele 7
AE - Emirati Arabi Uniti 6
BY - Bielorussia 6
EG - Egitto 6
HR - Croazia 6
LT - Lituania 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
AL - Albania 5
BH - Bahrain 5
HN - Honduras 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
HT - Haiti 4
KG - Kirghizistan 4
RO - Romania 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
KW - Kuwait 3
LU - Lussemburgo 3
MM - Myanmar 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
SV - El Salvador 3
TW - Taiwan 3
AO - Angola 2
BN - Brunei Darussalam 2
CY - Cipro 2
DZ - Algeria 2
EE - Estonia 2
GD - Grenada 2
GR - Grecia 2
IM - Isola di Man 2
IR - Iran 2
LB - Libano 2
ME - Montenegro 2
Totale 43.048
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.978
Ashburn 1.737
Dong Ket 1.474
Ann Arbor 1.448
Chandler 1.364
Wilmington 1.317
Seattle 1.088
San Jose 1.080
Dallas 1.016
Cambridge 933
Dearborn 890
Jacksonville 779
Singapore 670
Southend 630
Nyköping 614
Boardman 475
Moscow 428
Beijing 379
Council Bluffs 286
Lawrence 258
Princeton 258
The Dalles 208
Ogden 178
Düsseldorf 137
Los Angeles 128
Shanghai 127
Ho Chi Minh City 124
Des Moines 115
Phoenix 115
Kraków 108
Hanoi 94
Yubileyny 90
San Diego 89
Hutchinson 88
Helsinki 82
Bremen 75
Hong Kong 75
New York 73
Santa Clara 68
Grafing 66
Nanjing 62
São Paulo 59
Jinan 55
London 54
Chicago 49
Hefei 40
Frankfurt am Main 33
Tokyo 33
Edinburgh 28
Norwalk 28
Brussels 27
Rome 27
Shenyang 27
Amsterdam 26
Kunming 24
Munich 24
Riga 24
San Mateo 24
Baghdad 23
Da Nang 23
Guangzhou 22
Brooklyn 21
Montreal 21
Napoli 21
Nanchang 20
Naples 20
Rio de Janeiro 20
Belo Horizonte 19
Tashkent 19
Atlanta 18
Auburn Hills 18
Milan 18
Chennai 17
Hanover 17
Zhengzhou 17
Boston 16
Mirabella Eclano 16
Taiyuan 16
Buffalo 15
Charlotte 15
Hangzhou 15
Curitiba 14
Dublin 14
Kilburn 14
Lake Worth 14
Toronto 14
Vienna 14
Hebei 13
Riyadh 13
Tianjin 13
Brasília 12
Changsha 12
Columbus 12
Falls Church 12
Saint Petersburg 12
Caracas 11
Hounslow 11
Johannesburg 11
Totale 27.755
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 472
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 334
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 308
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 273
Effects of physical exercise on the female reproductive system. 259
The good and bad effects of statins on insulin sensitivity and secretion 254
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 251
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 249
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 245
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 244
Secrezioni ormonali ectopiche 242
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 238
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 235
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 231
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 229
Cardiological aspects of growth hormone and insulin-like growth factor-I. 228
Endocrine secretions under abnormal light-dark cycles and in the blind. 227
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 227
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 221
Failure of long-term therapy with sodium valproate in Cushing's disease. 218
Vitamin D and thyroid disease: to D or not to D? 218
Adiponectin levels in women with polycystic ovary syndrome 218
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 216
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 215
Height, weight, height velocity of primary school population sample in Campania region. 214
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 211
Ovulation induction in polycystic ovary syndrome 211
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 211
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 211
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 210
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 210
Lifestyle changes in the management of adulthood and childhood obesity. 210
Effects of neridronate treatment in elderly women with osteoporosis 209
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 207
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 206
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 206
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 205
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 205
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 204
Effect of growth hormone on cardiac function. 202
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 202
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 202
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 202
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 201
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 201
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 201
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 201
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 201
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 200
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 200
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 199
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 199
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 199
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 198
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. 198
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 198
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome 198
Adrenocortical tumors and insulin resistance. What is the first step? 198
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 197
Auditory brainstem responses in thyroid diseases before and after therapy. 197
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 197
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 197
Growth hormone status in morbidly obese subjects and correlation with body composition 196
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 196
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 196
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 194
Thyroid function and morphology after a successful kidney transplantation 194
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 193
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 193
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 193
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 193
Does raloxifene inhibit the growth of uterine fibroids? 192
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. 192
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 192
Antisperm antibodies in cryptorchidism before and after surgery. 192
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 192
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 192
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 191
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 191
Terapia di associazione con insulina ed analoghi del GLP-1 190
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 190
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 189
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 188
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 188
Evidence for altered adipocyte function in polycystic ovary syndrome. 187
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 187
Circulating ghrelin concentrations in the polycystic ovary syndrome 187
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 187
Cardiovascular risk of women with polycystic ovary syndrome 187
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 186
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 186
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 186
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 185
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 184
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 184
Lymphocyte subset pattern in acromegaly. 184
Prevalence of polycystic ovary morphology in a region of South Italy. 184
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. 183
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome:A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial 183
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS) 182
Totale 20.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.676 0 0 0 771 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/20255.948 86 505 15 133 86 499 1.693 2.000 322 199 205 205
2025/20266.434 491 820 523 413 413 163 988 645 948 710 173 147
2026/20271.274 127 131 808 208 0 0 0 0 0 0 0 0
Totale 43.516